JNJ vs SOLV
By Alex · Tickerpine
Johnson & Johnson vs Solventum Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | SOLV |
|---|---|---|
| Price | $260.86 | $85.29 |
| Market cap | $628.65B | $14.52B |
| P/E ratio | 30.3 | 10.3 |
| ROE | 25.74% | 33.96% |
| Profit margin | 21.48% | 17.26% |
| Revenue growth | 6.60% | 2.20% |
| Dividend yield | 2.05% | — |
| Beta | 0.23 | 0.67 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs SOLV in plain English
- JNJ is the bigger company — about 43.3× the market cap of SOLV.
- SOLV is cheaper on earnings (P/E 10.3 vs 30.3).
- SOLV earns a higher return on equity (34% vs 26%).
- JNJ is growing revenue faster (7% vs 2%).
- JNJ pays a dividend (2.05%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
SOLV return calculator
See what $1,000 in Solventum Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.